Gynecologic Oncology Program Overview
Preventing, Detecting, & Treating Gynecologic Cancers
In combination, gynecologic cancers are the third most commonly diagnosed types of cancers in the United States. As a result, researchers have committed tremendous resources to making historic advancements in preventing, detecting, and treating gynecologic disorders and diseases. In fact, widespread use of the Pap test to detect cervical cancer has exponentially reduced the incidence of this malignancy, which was once common among American women. More recently, the introduction of HPV vaccines, which target the virus that causes the majority of cervical cancers, has been hailed as one of the most significant public health advancements in the last five decades. Through years of research and effort, we have gained valuable knowledge to treat deadly gynecologic cancers with powerful medicines, targeted radiation treatments, and effective surgeries using leading-edge robotic technology, including minimally invasive procedures. Despite these advances, millions of women throughout the world continue to be affected by gynecologic cancers, including the most common type, uterine or endometrial cancer, as well as cervical and ovarian cancer. Fortunately for women in South Florida, Mount Sinai Medical Center’s Comprehensive Cancer Center is home to an expert gynecologic oncology department led by nationally acclaimed physician-scientist, Dr. Brian Slomovitz, that incorporates the latest innovations in robotic surgery.Research Now. Research Here.
Director of Gynecologic Oncology Dr. Brian Slomovitz is a national and global leader in clinical research. He serves as a board member of the GOG Foundation, the leading national organization for investigating advances in the detection and treatment of gynecologic cancers. Due to the prestige and research focus he brings to the Mount Sinai program, female patients seeking care for gynecologic cancer may be able to participate in pioneering clinical trials testing the most sophisticated therapies that may not be available at most medical centers. Dr. Slomovitz leads all of the GOG Foundation’s endometrial cancer clinical trials and is at the front lines of improving progression-free survival for patients. Most recently, Dr. Slomovitz’s success in treating endometrial (uterine) cancer with immunotherapy improved overall survival rates for women with a particular genetic makeup. Through clinical trials such as these, Dr. Brian Slomovitz is changing the standard of care for women with advanced or recurrent endometrial cancer.A Multidisciplinary Approach with Academic Expertise
In addition to breakthrough medical treatments for gynecologic cancers, patients at Mount Sinai’s Comprehensive Cancer Center receive their care from an integrated team of physicians, working in concert to provide advanced robotic surgical interventions and advanced treatment plans, personalized to each patient’s needs and biological makeup. Our team includes expert surgeons who play a major role in the treatment process. Mount Sinai’s surgeons can often perform lifesaving, cancer-fighting surgeries with minimally invasive approaches that decrease scarring, reduce the risk of blood loss, and expedite the healing process.Prioritizing the Patient Experience
Every cancer diagnosis – or the possibility of a cancer diagnosis – brings unimaginable stress and anxiety. Within our gynecologic oncology program at Mount Sinai’s Comprehensive Cancer Center, we recognize the unique concerns of patients and families facing cancer. With this in mind, we have designed a “boutique” healthcare experience with a highly tailored approach to every facet of the treatment process. Mount Sinai’s gynecologic oncology program has received positive patient feedback for its quick appointment scheduling, seamless department integration, and unparalleled medical care that employs the latest in robotic surgery. A cancer diagnosis can alter the course of anyone’s life, but with Mount Sinai’s gynecologic oncology program, patients can now seek refuge in a team that aids in the fight.Our Physicians
- Mount Sinai Medical Center (Main Campus)
- 305.535.3464
Michael Alan Schwartz, MD
Principal Investigator, Mount Sinai Cancer Research Program
Assistant Professor at the Columbia University Division of Hematology/Oncology at Mount Sinai Medical Center
- Cancer
- Oncology
- Medical Oncology
- Hematology/Oncology
- Lung Cancer
- Mount Sinai Medical Center (Main Campus)
- 305.535.3300
- Mount Sinai Emergency Center, Physician Offices, Cancer Center and Diagnostic Center Aventura
- 305.692.5400
Debra Linzer, MD
- Cancer
- Radiation Oncology
- Mount Sinai Medical Center (Main Campus)
- 305.535.3400
- Mount Sinai Emergency Center, Physician Offices, Cancer Center and Diagnostic Center Aventura
- 305.692.5400